The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 68 | 18.5x | 20.1x | Above average | |
Growth | 34 | 4.1% | 5.6% | Below average | |
Quality | 49 | 5.4% | 7.6% | Near average | |
Safety | 37 | 5.0x | 0.4x | Near average | |
Capital Return | 25 | 1.81% | 2.19% | Below average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
CONMED Corporation is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy CONMED Corporation shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
The data shows stability in the average price target at 78 dollars despite a new analyst recently entering coverage, indicating a temporary consensus on fair value. However, a sharp dispersion in expectations stands out between the minimum of 61 dollars and the maximum of 95 dollars, reflecting operational uncertainty despite the significant gap between the current price (34.65) and the target.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.